Speaker illustration

Doctor Jacqueline Saw

Vancouver General Hospital, Vancouver (Canada)

Dr. Jacqueline Saw is an Interventional Cardiologist at Vancouver General Hospital and St Paul’s Hospital, Clinical Professor of Medicine at UBC, and Program Director of the VGH Interventional Cardiology Fellowship Program. She is an international key opinion leader in spontaneous coronary artery dissection (SCAD). She is the PI of the Canadian SCAD Study, Canadian SCAD Genetic Study, CanSCAD3000 Study, PRYME, NACAD, and SAFER-SCAD studies. She is a Michael Smith Foundation Health Research Professional Investigator for SCAD research. She is also a key opinion leader in left atrial appendage (LAA) closure, and is principal investigator of several LAA closure studies (ASAP-TOO, Canadian Watchman Registry, Canadian ACP/Amulet Registry). She has co-authored over 250 peer-reviewed publications, including scientific research manuscripts, review papers, and book chapters, and is also the editor of three textbooks on LAA closure and carotid artery stenting.

Myocardial infarction with nonobstructive coronary artery disease: case presentation

Event: ESC Congress 2023

Topic: Clinical

Session: Guidelines in Practice: myocardial infarction with nonobstructive coronary artery disease

Thumbnail

Management of spontaneous coronary artery dissection and shock

Event: ESC Congress 2023

Topic: Interventional Cardiology

Session: Management of cardiogenic shock: haemodynamic support device selection, avoiding complications and more

Thumbnail

Spontaneous coronary dissection.

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Acute coronary syndromes with non-obstructive coronary artery disease

Thumbnail

Recommendations from the Commission 1-5.

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in Special Populations

Session: Global burden of cardiovascular disease in women; 20/20 vision for 2030: report of The Lancet commission

Thumbnail

Canadian SCAD Study - Canadian Spontaneous Coronary Artery Dissection Cohort Study -

Event: ESC Congress 2018

Topic: Clinical, Other

Session: Late Breaking Science in Interventional Cardiology 1

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb